CareDx Inc. (NASDAQ: CDNA) announced a definitive agreement to acquire Naveris, a commercial-stage precision oncology diagnostics company, for $160 million ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE